Menu ×

HEALTHCARE & PHARMACEUTICAL

Injectable Drug Delivery Devices Market Segmentation by Product (Conventional Injection Devices, and Advanced Injection Devices); by Therapeutic Area (Cardiovascular Disease, Diabetes, Oncology, Autoimmune Disorders, and Others); by Route of Delivery (Intramuscular, Subcutaneous, and Intra Dermal); and by End-User (Hospitals & Clinics, Homecare Settings, and Others) – Global Demand Analysis and Opportunity Outlook 2030

  • Text Size:

Extensive insights into the Growth of Injectable Drug Delivery Devices Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

IN THE NEWS

  • January 2021: Novo Nordisk A/S, announced the approval from the US Food and Drug Administration for semaglutide, which is an injectable treatment for chronic weight management in adults such as high blood pressure, high cholesterol, and others.
  • August 2018: Antares Pharma, Inc., announced their strategic agreement with Pfizer Inc., for the development of drug device rescue pen called ‘QuickShot auto injector’.

Global Injectable Drug Delivery Devices Market Highlights 2022-2030

The global injectable drug delivery devices market is expected to witness growth by a CAGR of ~11% during the forecast period, i.e., 2022-2030. The growth of the global injectable drug delivery device market can be attributed to the increasing implementation of biologics, growing prevalence of chronic disorders, escalating incidence of needlestick injuries, and other benefits of injections. Factors such as safety syringes, prefilled syringes, auto-injectors, and others, have increased the demand for injectable drug delivery devices. Moreover, increasing prevalence of chronic diseases, such as, cardiovascular disease, cancer, auto-immune disease and diabetes, is expected to drive the demand for such devices. According to the report by the WHO, 422 million people have diabetes on a global level, and 1.6 million deaths are directly attributed to diabetes each year. Moreover, Cardiovascular diseases (CVD) are currently the leading cause of deaths and disability worldwide causing around 17.9 million deaths globally. The need for self-injections in homecare settings without the requirement of any professional help for the treatment of these diseases is estimated to act as a major growth driver for the market.

Global-Injectable-Drug-Delivery-Devices-Market-Overview

The global injectable drug delivery devices market is segmented on the basis of product into conventional injection devices, and advanced injection devices, out of which, the advanced injection devices segment is expected to grab the largest market share in the forecast period, on the back of its advantages, such as, convenient application and low healthcare cost. CLICK TO DOWNLOAD SAMPLE REPORT

Based on end-user, the hospital & clinics segment is expected to gain largest share in terms of revenue, on the back of increasing patient influx and longer stay of the patients at the hospitals suffering from chronic diseases.  

Major Macro-Economic Indicators Impacting the Market Growth

Global-Healthcare-Expenditure-per-Capita

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Injectable Drug Delivery Devices Market Regional Synopsis

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia-Pacific region is estimated to witness remarkable CAGR over the forecast period, on the back of increasing incidence of chronic disorders in the APAC countries backed by the increasing aging population. Additionally, the increasing healthcare expenditure and growing development of advanced injectable devices for drug delivery in the region are expected to drive the market growth.

Furthermore, in 2030, the market in the North America region is expected to hold the most significant share in the global injectable drug delivery market, on the back of a higher rate of implementation of innovative injectable drug delivery devices for the treatment of various diseases, such as, diabetes mellitus, autoimmune disorders, cancers, and others. Additionally, the rising prevalence of cancer cases and diabetes in the United States is expected to promote the growth of the North America injectable drug delivery market.

Global-Injectable-Drug-Delivery-Devices-Market-Size

The global injectable drug delivery devices market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global injectable drug delivery devices market includes the following segments:

By Product

  • Conventional Injection Devices
  • Advanced Injection Devices
    • Injectable Pens
    • Auto Injectors
    • Prefilled Syringe
    • Needle-free Injectors
    • Others

By Therapeutic Area

  • Cardiovascular Disease
  • Diabetes
  • Oncology
  • Autoimmune Disorders
  • Others

By Route of Delivery

  • Intramuscular
  • Subcutaneous
  • Intra Dermal

By End-User

  • Hospitals & Clinics
  • Homecare Settings
  • Others

Growth Drivers

  • Emergence of Self-Injectors
  • Increasing Incidence of Chronic Diseases

Challenges

  • Injuries & Infections Caused by Needles
  • Increasing Use of Alternative Delivery Methods

Top Featured Companies Dominating the Market

  •  Baxter International Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Eli Lilly and Company
  • West Pharmaceutical Services Inc.
  • Pfizer Inc.
  • Schott AG
  • Becton, Dickinson and Company
  • Teva Pharmaceutical Industries Ltd
  • Gerresheimer AG
  • Novo Nordisk A/S
  • Terumo Corporation

 

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved